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Sinonasal carcinosarcomas represent rare neoplasms, with aggressive character and unfavourable prognosis. We present a case of
extensive sinonasal carcinosarcoma extending into the anterior cranial fossa and into the orbit and also a review of the current
international literature regarding this rare yet aggressive neoplasm. )ere is currently a lack of specific guidelines on the optimal
management of sinonasal carcinosarcoma and the treatment represents a challenge for the clinician. )e key message that we
would like to disseminate to our colleagues is the importance of suspicion and early detection, as well as the necessity to adopt
a holistic approach when counselling patients.
1. Introduction
A malignant biphasic neoplasm consisting of an epithelial
(squamous) element and mesenchymal component is
known as a carcinosarcoma (also known as pleomorphic
carcinoma, spindle cell carcinoma, pseudosarcoma, and
pseudosarcomatous squamous cell carcinoma) [1, 2] al-
though the exact nomenclature and subclassifications are
variable [3]. It is classified under squamous cell carcinoma
by the World Health Organization (WHO) [4].
Carcinosarcoma may arise from any squamous epithe-
lium (e.g., salivary glands, respiratory tract, upper aero-
digestive tract, and female reproductive organs) [5], but its
occurrence in the sinonasal region is extremely rare [1].)ere
is very little evidence available about its best management.
2. Case Presentation
A 75-year-old gentleman first presented to primary care
with a three month history of left-sided headaches and
diplopia. He also complained of altered taste sensation and
paraesthesia in the left maxillary region. )ere was no
history of epistaxis. )e patient attended his general prac-
titioner on multiple occasions and was given sinusitis
treatment until a CT scan was finally performed due to
persistence of symptoms, upon which the patient was then
referred to the ENT service.
He has a background history of fast atrial flutter
(on bisoprolol), hypertension, polymyalgia rheumatica,
benign prostatic hyperplasia, and previously excised papil-
lary squamous cell carcinoma in the left thigh. He quit
smoking 40 years prior to presentation. Otherwise, he had
lived independently with WHO performance status of 1
(Karnofsky status 90).
)e patient underwent complete head and neck exam-
ination including flexible nasoendoscopy. )ere was no
discreet neck lymphadenopathy. Nasoendoscopy revealed
a mass down to the left inferior turbinate obscuring the left
nasal cavity. He complained of diplopia on the left side on
the lateral gaze with proptosis of approximately 3mm
compared to the contralateral side. Vision was 6/30 bi-
laterally with glasses. )ere was no relative afferent pupillary
defect or papilloedema.
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2.1. Investigations. Initial CT scan revealed an aggressive
lesion in left ethmoidal and frontal sinuses, invading the left
orbit and anterior cranial fossa. CTneck and thorax showed
no cervical or chest lymphadenopathy.
Subsequent MRI imaging also showed evidence of bone
erosion with breaching of the dura in the vicinity of the
left orbitofrontal cortex although there was no signal change
in the brain to suggest brain invasion (Figure 1). )ere was
destruction of left lamina papyracea. An incidental right
anterior cranial fossa meningioma, distant from sinonasal
lesion was also identified.)is pathologic finding did not have
any significant clinical relevance with the primary disease.
A staged whole body positron-emission tomography
(PET) scan showed no other distant lesions but confirmed
lesion progression through the frontal sinus.
Our initial differential diagnoses were squamous cell
carcinoma, carcinosarcoma, lymphoma, teratocarcinosar-
coma, olfactory neuroblastoma, small cell carcinoma and
alveolar rhabdomyosarcoma.
2.2. Treatment. After the diagnostic workup, the patient
underwent endoscopic examination of the nose and biopsy
of the lesion under general anaesthesia. Extensive disease
was noted at the ipsilateral maxillary antrum. Histology
revealed an extensive necrotic biphasic epithelioid, spindled
malignant neoplasm in keeping with carcinosarcoma. Im-
munohistochemistry afterwards showed no loss of DNA
mismatch repair (MMR) protein expression.
2.3. Outcome. After a successful biopsy and radiological
investigative workup, the patient was discharged home.
Unfortunately in the community, his preexisting comor-
bidities worsened, and he developed poorly controlled fast
atrial flutter and urosepsis with E. Coli bacteraemia. He was
readmitted for antimicrobial and supportive treatment. )e
patient eventually recovered and was discharged.
Discussion was undertaken at the multidisciplinary
meeting and with international experts in the field. )e
consensus is that although the disease can potentially be
resected with major surgery such as craniofacial resection,
due to its location and size, surgical treatment would have
significant risk of bleeding, cerebrospinal fluid (CSF) leak,
and meningitis. After detailed consultation and discussion
about the possible treatment options including the risks of
such procedures with the patient and his family, he was not
keen to proceed and opted for palliative radiotherapy and
symptomatic management.
)e radiotherapy dose delivered was 20Gy in five days,
then a two-week break and finally another 20Gy in five days.
One year after diagnosis, patient tolerated the radiotherapy
and continued to lead an independent life.
3. Discussion
In the head and neck area, carcinosarcomas most frequently
occur in the larynx and oral cavity, followed by the skin,
tonsils, sinonasal tract, pharynx and hypopharynx [6, 7].
Histologically, they have been classified as part of a spectrum
of sarcomatoid carcinomas, most of which present in late
middle-aged men with a long history of tobacco use. )ey
consist of foci of overt carcinoma admixed with areas of di-
vergent differentiation into mesenchymal tissues [8]. Spindle
cell formation is also typical in the sarcomatous component. A
recent study suggested that a MET protooncogene mutation
may be a prerequisite event in its pathogenesis [9].
Presenting symptoms of sinonasal carcinosarcomas
typically include nasal obstruction, epistaxis, facial pain, and
headache [10, 11].)ese are rather nonspecific to the disease.
)ey tend to grow rapidly, with extensive local destruction.
)erefore, early diagnosis and aggressive therapy are nec-
essary to improve the often dismal prognosis [2, 8].
In a Japanese case report of maxillary carcinosarcoma,
the patient died despite intensive radiochemotherapy and
total maxillectomy due to rapid tumour recurrence and me-
tastasis. However, it appeared the carinomatous component
(a)
(b)
Figure 1: MRI head scan shows breaching of dura mater. Red
arrow denotes lesion of interest. (a) Axial slide. (b) Coronal slide.
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Table 1: Cases of sinonasal carcinosarcoma that are reported in the literature.
Number Age (years)/sex Location Stage Treatment Outcome Author, year
















et al., 1982 [16]
3 65/F Maxillary sinus ND TM+RT LR, DWD 8 monthslater
Ampil, 1985
[14]









5 60/M Nasomaxillary sinus T3N0M0 TM+RT+CT
LR, DWD 2 months
later (diffuse metastasis
in lung and brain)
Sonobe, 1989
[11]
6 53/M Maxillary + ethmoidsinuses T4aN0M0
TM+ craniofacial
resection +RT+CT




7 81/F Maxillary sinus T3N0M0 TM+RT+ 2ndoperation




8 47/M Maxillary sinus ND PM+RT LR, DWD after 1 year Furuta et al.,2001 [10]


























5 with disease at last
follow-up
0 death at follow-up
Doshi et al.,
2010 [15]




12 60/M Maxillary sinus andnasal cavity Unclear CT+RT DWD after 9 months
Terada, 2011
[29]
13 29/F Nasopharyngeal T1N2cM0 RT
Clinically free-of-
disease 2 months after
RT
Lim et al., 2012
[22]
14 60/M Maxillary + ethmoidsinuses T3N0M0 TM+RT+CT LR, FL
Moon, 2013
[1]
















































19 66/M Maxillary sinus T3N0M0 PM+RT+CT LR, DWD 10 monthsafter initial presentation
Ando et al.,
2015 [9]
20 78/F Ethmoid sinus T4N0M0 Surgery +RT Disease-free after 36months
Iqbal et al.,
2015 [20]
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responded to the radiochemotherapy but that was not the case
with the sarcomatous component [11].
Nonetheless, aggressive treatment may not cease disease
progression and improve survival. Cheong et al. [12] re-
ported on a 61-year-old male patient who underwent total
maxillectomy and modified radical neck dissection and died
shortly afterwards with sternal metastasis, despite having
had extensive surgery with curative intent.
Table 1 shows the similar cases of sinonasal carcino-
sarcoma reported in the literature [1, 2, 9–31]. )e optimal
treatment of this disease remains undetermined. It is difficult
to ascertain the effectiveness of the treatment modalities (a
combination of surgery, radiotherapy, and chemotherapy)
from the small number of cases available in the literature.
)ey generally confer a poor outcome and a high recurrence
rate. A recent large case-control analysis of 15 sinonasal
patients in America showed an average five-year disease-
specific survival of 48.5%, which is significantly poorer than
controls with carcinosarcoma at other anatomical sites [5].
)erefore we advocate, when patients are operatively fit with
resectable disease, they should undergo aggressive surgical
treatment with adjuvant radiotherapy as an attempt to
improve outcome. )is is because radiotherapy alone tends
to convey a less favourable outcome, and the role of che-
motherapy is unclear.
Since the optimalmanagement of carcinosarcoma remains
uncertain, it is intuitive to study a related but separate (also
highly aggressive) entity known as teratocarcinosarcoma
[26, 33–35]. )is tumour type also includes a component of
neuroectodermal tissue and is much more prevalent in the
medical literature. According to a recent systemic review of 49
patients, it is recommended that optimal treatment involves
radical surgical resection followed by radiation therapy [25].
If more doctors are aware of this condition and the
associated presenting symptoms, perhaps earlier diagnoses
can be made. )erefore, patients may potentially get the
option of a curative total resection, since the invasion of the
skull base and surrounding structures is a poor prognostic
factor.
In conclusion, sinonasal carcinosarcomas represent rare
neoplasms, with aggressive character and unfavourable
prognosis. Here we present a case of extensive sinonasal
carcinosarcoma extending into the anterior cranial fossa and
into the orbit and also a review of the current international
literature regarding this rare yet aggressive neoplasm. )ere
is currently a lack of specific guidelines on the optimal
management of sinonasal carcinosarcoma, and the treat-
ment represents a challenge for the clinicians. )e key
message that we would like to disseminate to our colleagues
is the importance of suspicion and early detection, as well as
the necessity to adopt a holistic approach when counselling
patients.
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